Author

Harshit Shah

Cancer Research UK Scotland InstituteORCID 0000-0001-6138-6291Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Amna MatlyiD· 1 shared Bojie CongiD· 1 shared Evangelia Stamou· 1 shared Joanne EdwardsiD· 1 shared Kathryn A.F. PenneliD· 1 shared Kathryn L. GilroyiD· 1 shared Molly McKenzieiD· 1 shared Ross Leigh CaganiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amna MatlyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyEMBO ReportsPeer-reviewedNov 4, 2025

WNT Signalling Promotes NF-κB Activation and Drug Resistance in KRAS-Mutant Colorectal Cancer

Bojie Cong, Evangelia Stamou, Kathryn A.F. Pennel…·Ross Leigh Cagan

This study shows that WNT signaling enhances NF-κB activation and drug resistance in KRAS-mutant colorectal cancer, suggesting a therapeutic strategy targeting WNT and MEK pathways.

5 citations

humanbulk RNA-seq

𝕏 PostBluesky